These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3030314)
1. Do myc, fos and E1A function as protein phosphatase inhibitors? Rechsteiner M Biochem Biophys Res Commun; 1987 Feb; 143(1):194-8. PubMed ID: 3030314 [TBL] [Abstract][Full Text] [Related]
2. Induction of c-fos mRNA and AP-1 DNA-binding activity by cAMP in cooperation with either the adenovirus 243- or the adenovirus 289-amino acid E1A protein. Engel DA; Muller U; Gedrich RW; Eubanks JS; Shenk T Proc Natl Acad Sci U S A; 1991 May; 88(9):3957-61. PubMed ID: 1850843 [TBL] [Abstract][Full Text] [Related]
3. E1A-dependent trans-activation of the c-fos promoter requires the TATAA sequence. Simon MC; Rooney RJ; Fisch TM; Heintz N; Nevins JR Proc Natl Acad Sci U S A; 1990 Jan; 87(2):513-7. PubMed ID: 2137244 [TBL] [Abstract][Full Text] [Related]
4. Anatomy of fos proteins. Vingron M; Nordheim A; Müller R Oncogene Res; 1988; 3(1):1-7. PubMed ID: 3144693 [No Abstract] [Full Text] [Related]
5. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Hiebert SW; Lipp M; Nevins JR Proc Natl Acad Sci U S A; 1989 May; 86(10):3594-8. PubMed ID: 2524830 [TBL] [Abstract][Full Text] [Related]
6. The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1. van Dam H; Offringa R; Smits AM; Bos JL; Jones NC; van der Eb AJ Oncogene; 1989 Oct; 4(10):1207-12. PubMed ID: 2529466 [TBL] [Abstract][Full Text] [Related]
7. Promoter trans-activation of protooncogenes c-fos and c-myc, but not c-Ha-ras, by products of adenovirus early region 1A. Sassone-Corsi P; Borrelli E Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6430-3. PubMed ID: 2957694 [TBL] [Abstract][Full Text] [Related]
8. Separation of immortalization and T24-ras oncogene cooperative functions of adenovirus E1a. Kuppuswamy M; Subramanian T; Chinnadurai G Oncogene; 1988 Jun; 2(6):613-5. PubMed ID: 2968534 [TBL] [Abstract][Full Text] [Related]
10. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes. Kohl NE; Ruley HE Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582 [TBL] [Abstract][Full Text] [Related]
11. [Role of the TCF phosphorylation state and the chromatin structure in the negative transcription regulation of the c-fos proto-oncogene in E1A + c-Ha-ras transformed cells]. Abramova MV; Kukushkin AN; Pospelova TV; Svetlikova SB; Pospelov VA Mol Biol (Mosk); 2002; 36(1):66-75. PubMed ID: 11862715 [TBL] [Abstract][Full Text] [Related]
12. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products. Moran E Nature; 1988 Jul; 334(6178):168-70. PubMed ID: 2968523 [TBL] [Abstract][Full Text] [Related]
13. Interactions between adenovirus E1A and members of the AP-1 family of cellular transcription factors. Maguire K; Shi XP; Horikoshi N; Rappaport J; Rosenberg M; Weinmann R Oncogene; 1991 Aug; 6(8):1417-22. PubMed ID: 1832215 [TBL] [Abstract][Full Text] [Related]
14. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Ciechanover A; DiGiuseppe JA; Bercovich B; Orian A; Richter JD; Schwartz AL; Brodeur GM Proc Natl Acad Sci U S A; 1991 Jan; 88(1):139-43. PubMed ID: 1846034 [TBL] [Abstract][Full Text] [Related]
15. The protein phosphatase 1/2A inhibitor okadaic acid increases CREB and Elk-1 phosphorylation and c-fos expression in the rat striatum in vivo. Choe ES; Parelkar NK; Kim JY; Cho HW; Kang HS; Mao L; Wang JQ J Neurochem; 2004 Apr; 89(2):383-90. PubMed ID: 15056282 [TBL] [Abstract][Full Text] [Related]
16. Negative regulation of c-myc transcription involves myc family proteins. Cleveland JL; Huleihel M; Bressler P; Siebenlist U; Akiyama L; Eisenman RN; Rapp UR Oncogene Res; 1988; 3(4):357-75. PubMed ID: 2976141 [TBL] [Abstract][Full Text] [Related]
17. Trans-activation of human MYC: the second promoter is target for the stimulation by adenovirus E1a proteins. Lipp M; Schilling R; Bernhardt G Oncogene; 1989 May; 4(5):535-41. PubMed ID: 2471129 [TBL] [Abstract][Full Text] [Related]
18. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein phosphatase PP1 in GH3B6, but not in GH3 cells, activates the MEK/ERK/c-fos pathway and the human prolactin promoter, involving the coactivator CPB/p300. Manfroid I; Martial JA; Muller M Mol Endocrinol; 2001 Apr; 15(4):625-37. PubMed ID: 11266513 [TBL] [Abstract][Full Text] [Related]
20. E1A products of adenoviruses reduce the expression of cellular proliferation-associated genes. Timmers HT; De Wit D; Bos JL; Van der Eb AJ Oncogene Res; 1988; 3(1):67-76. PubMed ID: 2974528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]